NCT00060359
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +32 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Clinical trial condition
Ovarian Mucinous Cystadenocarcinoma
Explore clinical trials studying Ovarian Mucinous Cystadenocarcinoma. Study availability and eligibility vary by location and protocol.
17 public trials
0 recruiting studies
Ovarian Mucinous Cystadenocarcinoma trial results
NCT00814086
- Conditions
- Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Cooper Hospital University Medical Center Camden, New Jersey, United States
- Riverside Methodist Hospital Columbus, Ohio, United States
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +31 more
- Locations
-
- Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
NCT00002913
- Conditions
- Adnexal Diseases, Brenner Tumor, Carcinoma, +29 more
- Locations
-
- Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
NCT01081262
- Conditions
- Adnexal Diseases, Borderline Ovarian Mucinous Tumor, Endocrine Gland Neoplasms, +38 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
Active, Not Recruiting
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
NCT02142803
- Conditions
- Adnexal Diseases, Adult Glioblastoma, Astrocytoma, +47 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Charlestown, Massachusetts, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02101775
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +33 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States